Search Results
398 results
Your search is now limited to «Roche» expert search.
FiercePharmaManufacturing 03/22/2019 02:03
AbbVie and Roche have been working to expand Venclexta’s reach, racking up two new approvals in 2018 and posting positive CLL combo data alongside Roche’s Gazyva, too.
More from FiercePharmaManufacturing:
Seeking Alpha 03/22/2019 01:52
The main drivers of value creation over time are growth and return on invested capital (in relation to cost of capital). Growth is often fleeting and decays fas.
More from Seeking Alpha:
Fiji Times (Fiji) 03/21/2019 22:20
ZURICH (Reuters) – Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker’s latest case targeting what it calls fraudulent schemes involving its diabetes test strips. Roche has filed several lawsuits in U.S. federal court in which it alleges individuals and companies obtained low-priced diabetes […]
ETHealthWorld (India) 03/21/2019 21:08
Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker's latest case targeting what it calls fraudulent schemes involving its diabetes test strips.
More from ETHealthWorld (India):
Becker's Hospital Review 03/21/2019 13:51
Roche sues US execs, says diabetes test strips fraudulently resold.
More from Becker's Hospital Review: 03/21/2019 10:21
Roche launches NAVIFY Mutation Profiler and NAVIFY Therapy Matcher to support comprehensive genomic profiling in cancer.
More from
MedCity News 03/20/2019 13:35
AbbVie said Tuesday that the FDA had placed a partial clinical hold on all Venclexta studies in myeloma due to a higher rate of deaths in the Phase III BELLINI study.
More from MedCity News:
BioPharma Dive 03/20/2019 12:15
A higher proportion of deaths were observed in the treatment arm versus control group of a study testing Venclexta in the blood cancer.
More from BioPharma Dive:
pharmaphorum 03/20/2019 07:18
AbbVie and Roche have stopped recruiting patients for all multiple myeloma trials involving the drug venetoclax after a higher proportion of deaths was observed in patients receiving it than in a trial’s control arm.
More from pharmaphorum:
World Pharma News 03/20/2019 07:00
About Roche in cancer immunotherapy For more than 50 years, Roche has been developing medicines with the goal to redefine treatment in oncology.
More from World Pharma News:
Pharmafile 03/20/2019 06:38
Roche's Tecentriq chalks up another FDA approval, this time in first-line extensive-stage small cell lung cancer.
More from Pharmafile:
(MENAFN - iCrowdNewsWire) iCrowdNewswire - Mar 20, 2019 "Global Hepatitis Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry ...
More from Middle East North Africa Financial Network (MENAFN): 03/19/2019 14:12
Roche Canada:
More from

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications